✦ LIBER ✦

CV4 IRBESARTAN IS PROJECTED TO BE COST AND LIFE SAVING IN THE FRENCH SETTING FOR TREATMENT OF PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION, AND MICROALBUMINURIA

✍ Scribed by AJ Palmer; L Annemans; S Roze; M Lamotte; P Lapuerta; S Gabriel; R Chen; P Carita; I Villadary; R Rodby; D de Zeeuw; HH Parving

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irbesartan is projected to be cost and l

✍ Palmer, Andrew J.; Annemans, Lieven; Roze, Stephane; Lapuerta, Pablo; Chen, Rola 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

CS3 IRBESARTAN IS PROJECTED TO BE COST A

✍ AJ Palmer; S Roze; Valentine Wj; L Annemans; S Gabriel; R Chen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV51 IRBESARTAN IS COST-SAVING COMPARED

✍ AJ Palmer; K Borsos; S Roze; L Annemans; M Lamotte; R Rodby; WJ Valentine 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PCV72 COST-EFFECTIVENESS ANALYSIS OF ADD

✍ P Kutscherauer; R Kodym; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB